Australia markets closed

Alpine Immune Sciences, Inc. (ALPN)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
64.57+0.02 (+0.03%)
At close: 04:00PM EDT
64.55 -0.02 (-0.03%)
After hours: 07:06PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-32,184
-32,184
-57,762
-50,333
-27,940
Depreciation & amortisation
576
576
597
620
578
Deferred income taxes
155
155
46
-214
-
Stock-based compensation
10,630
10,630
9,648
6,240
4,140
Change in working capital
-50,161
-50,161
4,146
27,255
52,937
Accounts receivable
225
225
24,602
0
0
Other working capital
-79,499
-79,499
-44,166
-15,366
29,282
Other non-cash items
45
45
178
274
261
Net cash provided by operating activities
-79,012
-79,012
-43,754
-15,248
30,084
Cash flows from investing activities
Investments in property, plant and equipment
-487
-487
-412
-118
-802
Purchases of investments
-351,347
-351,347
-266,984
-133,518
-101,328
Sales/maturities of investments
296,275
296,275
154,048
81,156
29,311
Net cash used for investing activities
-55,559
-55,559
-113,348
-52,480
-72,819
Cash flows from financing activities
Debt repayment
-3,425
-3,425
-4,800
-2,400
0
Common stock issued
161,905
161,905
106,716
102,662
56,258
Net cash used provided by (used for) financing activities
165,122
165,122
102,689
100,764
61,381
Net change in cash
30,559
30,559
-54,531
32,948
18,704
Cash at beginning of period
13,630
13,630
68,161
35,213
16,509
Cash at end of period
44,189
44,189
13,630
68,161
35,213
Free cash flow
Operating cash flow
-79,012
-79,012
-43,754
-15,248
30,084
Capital expenditure
-487
-487
-412
-118
-802
Free cash flow
-79,499
-79,499
-44,166
-15,366
29,282